You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

US Patent Family Members and Approved Drugs for Russian Federation Patent: 2591083

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for Russian Federation Patent: RU2591083

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
US Patent Number Estimated Patent Expiration Generic Name US Applicant US Tradename
  Start Trial 2030-10-08 infliximab Centocor Inc REMICADE
  Start Trial 2030-10-08 etanercept Immunex ENBREL
  Start Trial 2030-10-08 adalimumab Abbvie Inc HUMIRA
  Start Trial 2030-10-08 ustekinumab Centocor Ortho Biotech Inc STELARA
  Start Trial 2030-10-08 golimumab Centocor Ortho Biotech Inc SIMPONI
  Start Trial 2030-10-08 golimumab Janssen Biotech SIMPONI ARIA
>US Patent Number >Estimated Patent Expiration >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.